Article

Potential role of γδ T cell-derived IL-17 in acute cardiac allograft rejection.

Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California 94305, USA.
The Annals of thoracic surgery (Impact Factor: 3.45). 05/2012; 94(2):542-8. DOI: 10.1016/j.athoracsur.2012.03.049
Source: PubMed

ABSTRACT Although αβ T cells are known to participate in the development of acute cardiac allograft rejection, the role of γδ T cells remains poorly understood. We hypothesized that γδ T cells contribute to acute allograft rejection thru interleukin (IL)-17 production.
Donor hearts from FVB mice (H-2q) were heterotopically transplanted into C57BL/6-wild type (WT) and γδ T cell-deficient (TCRδ-/-) recipient mice (H-2b). Overall graft survival was monitored. Graft infiltrating cell profile, including γδ T cell subtype, cytokine expression, and myeloperoxidase activity were measured by flow cytometry, TaqMan (Applied Biosystems, Carlsbad, CA) polymerase chain reaction, and myeloperoxidase assay, respectively, on postoperative days 3 and 6.
Graft survival was prolonged in TCRδ-/- recipients compared with WT controls. Graft infiltrating cells, including CD45+, CD4+, CD8+, and Gr1+ cells were significantly decreased in TCRδ-/- recipients compared with WT. Donor hearts transplanted into TCRδ-/- recipients had reduced IL-17 and IL-6 messenger RNA expression. Corroborating the gene expression, intracellular cytokine staining showed decreased IL-17 producing cells in TCRδ-/- recipients. Finally, Vγ1+ and Vγ4+ T cells did not produce IL-17, although both represent 20% to 30% total graft infiltrating γδ T cells.
The γδ T cells promote acute cardiac allograft rejection, presumably by producing IL-17. The γδ T cell depletion may prove beneficial in prolonging allograft survival by suppressing IL-17 production.

0 Bookmarks
 · 
103 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: Th17 and γδ T cells are the dominant IL-17-producing cell. We previously reported that high mobility group box 1(HMGB1) is critical in inducing IL-17-producing alloreactive T cells during early stage of acute allograft rejection. However, the role of γδ T cells during this process and its implication in HMGB1-mediated allograft rejection are not fully understood. Here, we use a murine model of cardiac allograft transplantation to further study the role of HMGB1 and IL-17-producing γδ T cells in acute allograft rejection. It was found that the expression of HMGB1 was increased in allograft, while blockade of HMGB1 suppressed IL-17(+) γδ T cells response and inhibited the gene transcription of IL-23 and IL-1β. Furthermore, in vitro, HMGB1 indirectly promoted the development of IL-17(+) γδ T cells by stimulating dendritic cells to produce IL-23 and IL-1β, meanwhile depletion of γδ T cells in vivo prolonged allograft survival and reduced the level of IL-17 in serum. In conclusion, our findings inferred that increased HMGB1 expression could enhance IL-17(+) γδ T cells response by promoting the secretion of IL-23 and IL-1β, while IL-17(+) γδ T cells contribute to the early stage of acute allograft rejection. This article is protected by copyright. All rights reserved.
    Transplant International 01/2014; · 3.16 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND: γδ T cell comprise about 5% of the overall T cell population and they differ from conventional αβ T cells. Previous papers have indicated the contribution of γδ T cell to acute allograft rejection, but the role of γδ T cell in cardiac allograft vasculopathy is not investigated. METHODS: Hearts of adult B6.C-H-2(bm12) KhEg were heterotopically transplanted into major histocompatibility complex (MHC) class‖-mismatched C57BL/6 mice (wild-type, γδ TCR(-/-) ), which is an established murine model of chronic allograft rejection without immunosuppression. The survival of grafts was monitored daily by abdominal palpation until the complete cessation of cardiac contractility. RESULTS: Our current study demonstrated that γδ TCR deficiency significantly attenuated cardiac allograft vasculopathy, and this effect coincide with low expression of Hmgb1, IFN-γ and IL-17 while increased number of CD4(+) CD25(+) Foxp3(+) regulatory T cells, and depletion of regulatory T cells abrogated the prolonged allograft survival induced by γδ TCR deficiency. CONCLUSIONS: γδ TCR deficiency resulted in attenuated cardiac allograft vasculopathy and prolonged graft survival in murine models of cardiac transplantation, and this effect was associated with enhanced expansion of regulatory T cells. This article is protected by copyright. All rights reserved.
    Scandinavian Journal of Immunology 05/2013; · 2.20 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Suppressor of cytokine signaling 3 (SOCS3) is the main negative feedback regulator of cytokine signals. We investigated the hypothesis that overexpression of SOCS3 in a murine cardiac allograft transplantation model may result in a survival advantage of the allograft by attenuating alloreactive T-cell responses. With the use of BALB/c (H-2(d) ) donor mice and C57Bl/6j (H-2(b) ) recipient mice, the murine cardiac transplantation model was established. Recipient mice received tail intravenous injection with eukaryotic expression plasmid pEF-FLAG-I/mSOCS3 before and after transplantation. Heart beat of the grafts and immune responses were monitored. Overexpression of SOCS3 within grafts and spleens can prolong the survival time of cardiac allograft through attenuating inflammatory cells infiltration such as T cells and macrophages in the grafts, decreasing the number of CD4(+) IL-17(+) cells and CD8(+) IL-17(+) cells in spleens, and reducing the expression of STAT3 in grafts and phosphorylation of STAT3 in both grafts and spleens. Overexpression of SOCS3 significantly delays cardiac allograft acute rejection, which is associated with reduced allograft proinflammatory leukocytes infiltration and impaired alloreactive IL-17(+) T cell immunity. This article is protected by copyright. All rights reserved.
    The Journal of Gene Medicine 03/2014; · 2.16 Impact Factor